Patent · US Active

Efficient selectivity of recombinant proteins

US9732357B2 · kind B2 · utility

2Cited by
9References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 19, 2015
Grant dateAug 15, 2017
Priority date
Expiry dateSep 1, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides a new expression system comprising a mammalian selectable marker that promotes desirable post-translational modifications of glycoproteins. In particular, the invention includes methods and compositions for optimal recombinant protein expression in mammalian cells by employing a selection marker system based on GPT genes of mammalian origin. The invention includes methods that facilitate selectivity and enhanced expression copies as well as protein yield of recombinant proteins in mammalian cells, and methods of using GPT expression systems.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.